Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey

Supportive Care in Cancer

Volumn 14, Issue 12, 2006, Pages 1252-1257

  Kav, Sultan ^a   Bostanci, Humeyra ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Nursing; Oral chemotherapy; Patient education

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; ETOPOSIDE; HYDROXYUREA; MELPHALAN; METHOTREXATE; UFT;

AMBULATORY CARE; ARTICLE; CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CLINICAL PRACTICE; CLINICAL PROTOCOL; DOCTOR NURSE RELATION; DRUG INFORMATION; DRUG SAFETY; FOLLOW UP; HUMAN; NURSING CARE; NURSING KNOWLEDGE; OUTPATIENT DEPARTMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; TURKEY (REPUBLIC); UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; NURSE'S ROLE; PATIENT EDUCATION;

EID: 33751279400     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-006-0084-z     Document Type: Article

References (19)

1. Bedell CH (2003) A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):5-9
2. Birner A (2003) Pharmacology of oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):1-5
3. Birner A (2003) Safe administration of oral chemotherapy. Clin J Oncol Nurs 7:158-162
4. Borner M, Schithauer W, Twelves C, Maroun J, Wilke H (2001) Answering patients' needs: oral alternatives to intravenous therapy. Oncologist 6(Suppl 4):12-16
5. Chau I, Legge S, Fumoleau P (2004) The vital role of education and information in patients receiving capecitabine (Xeloda). Eur J Oncol Nurs 8(Suppl 1):41-53
6. Gerbrecht BM, Kangas T (2004) Implications of capecitabine (Xeloda) for cancer nursing practice. Eur J Oncol Nurs 8(Suppl 1):63-71
7. Griffin E (2003) Safety considerations and safe handling of oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):25-29
8. Hartigan K (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7(6):21-24
9. Hayden BK, Goodman M (2005) Chemotherapy: principles of administration. In: Yarbro CH, Frogge MH, Goodman M (eds) Cancer nursing principles and practice, 6th edn. Jones and Bartlett, Sudbury, pp 359-360
10. Hollywood E, Semple D (2001) Nursing strategies for patients on oral chemotherapy. Oncology 15(Suppl 2):37-40
11. Lebovits AH, Strain JJ, Schleifer SJ, Tanaka JS, Bhardwaj S, Meese MR (1990) Patient noncompliance with self-administered chemotherapy. Cancer 65:17-22
12. Levine AM, Richardson JL, Marks G, Chan K, Graham J, Selser JN et al (1987) Compliance with oral drug therapy in patients with hematologic malignancies. J Clin Oncol 5:1469-1476
13. Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15:110-115
14. McLeod HL, Evans WE (1999) Oral cancer chemotherapy: the promise and the pitfalls. Clin Cancer Res 5(10):2669-2671
15. McPherson CJ, Higginson IJ, Hearn J (2001) Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. J Public Health Med 23:227-234
16. O'Neill VJ, Twelves CJ (2002) Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer 87:933-937
17. Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94:652-661
18. Sharma S (2001) Patient selection for oral chemotherapy. Oncology 15(Suppl 2):33-35
19. van Eijken M, Tsang S, Wensing M, de Smet PA, Grol RP (2003) Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging 20(3):229-240